NCT06996509View on ClinicalTrials.gov

Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

November 1, 2026

Conditions
Guillain-Barre Syndrome
Interventions
DEVICE

Non-Invasive Ventilation (NIV)

Bi-Level NIV delivers two preset pressure levels-Inspiratory Positive Airway Pressure (IPAP) and Expiratory Positive Airway Pressure (EPAP)-via a tightly fitting mask interface

DEVICE

High Velocity Nasal Insufflation

High-Velocity Nasal Cannula therapy delivers heated, humidified gas at flow rates exceeding patients' peak inspiratory demands (35-60 L/min), with precise FiO₂ control up to 100 %

Trial Locations (1)

71515

Assuit Univeristy, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06996509 - Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome | Biotech Hunter | Biotech Hunter